Funding Details
- Awarder
- Inbox
- Date Award
- May 13, 2025
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
-
$18,000,000
Company Info
- Traction
- The company has raised a total of $55 million to date and is advancing RPT1G into Phase 1/2 clinical studies for patients with AML/MDS.
- Founders
- Greg Crimmins
- Company Description
- Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.
- Market
- Oncology and Autoimmunity
- Location
-
Gaithersburg,
Maryland,
United States
- Coinvestors
- Schooner Capital, Alexandria Venture Investments
Links